skip to main content
OSTI.GOV title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: Screening the dopamine D{sub 1} receptor gene in 131 schizophrenics and eight alcoholics: Identification of polymorphisms but lack of functionally significant sequence changes

Journal Article · · American Journal of Medical Genetics
; ;  [1]
  1. Mayo Clinic/Foundation, Rochester, MN (United States); and others

To determine whether mutations in the D{sub 1} dopamine receptor (D{sub 1}DR) gene are associated with schizophrenia, the coding sequence was examined in 106 Caucasian, 11 African-American, 8 Asian, and 6 Native American patients. Approximately 350 kb of genomic sequence was screened by dideoxy fingerprinting, a method related to single strand conformational polymorphism (SSCP) analysis that detects virtually 100% of sequence changes. One polymorphism was identified in Asians and one in Caucasians, but neither altered 421 the amino acid sequence (Leu{sup 66}, and Ser{sup 421}, respectively). In addition, a previously reported polymorphism in the 5{prime} untranslated region of exon 2 at bp -48 was found to be common, with an allele frequency of approximately 40% in Caucasians of Western European descent. Based on the fact that no sequence changes of likely functional significance were identified, these data suggest that mutations affecting the structure of the D{sub 1} dopamine receptor protein are uncommon and are unlikely to contribute significantly to the genetic predisposition to schizophrenia. The D{sub 1}DR gene also was examined in eight alcoholics, including 3 African-Americans and 1 Native American, but no sequence changes were identified. 35 refs., 1 fig., 3 tabs.

Sponsoring Organization:
USDOE
OSTI ID:
393900
Journal Information:
American Journal of Medical Genetics, Vol. 60, Issue 2; Other Information: PBD: 24 Apr 1995
Country of Publication:
United States
Language:
English